2021
DOI: 10.1101/2021.01.03.425155
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Lithium ions display weak interaction with amyloid-beta (Aβ) peptides and have minor effects on their aggregation

Abstract: Alzheimer’s disease (AD) is an incurable disease and the main cause of age-related dementia worldwide, despite decades of research. Treatment of AD with lithium (Li) has showed promising results, but the underlying mechanism is unclear. The pathological hallmark of AD brains is deposition of amyloid plaques, consisting mainly of amyloid-β (Aβ) peptides aggregated into amyloid fibrils. The plaques contain also metal ions of e.g. Cu, Fe, and Zn, and such ions are known to interact with Aβ peptides and modulate t… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 111 publications
(143 reference statements)
0
1
0
Order By: Relevance
“…3−5 Increasing evidence suggests that soluble Aβ oligomers are toxic and serve as critical targets for treating AD. 6,7 Aβs with 37 to 49 amino acid residues are the peptide fragments generated by proteolytic processing of the amyloid precursor protein (APP) (Figure 1a), 8 among which the product species with chains varying in length from 38 to 42, 9 namely, Aβ (1−38), Aβ (1−40), and Aβ (1−42), are commonly detected in preclinical and clinical AD samples. 10 Further, Aβ (1−40) and Aβ (1−42) are the main components of the progressive deposition of amyloid fibrils, 5,11 and Aβ(1−42) is considered to be more neurotoxic and greater aggregative than Aβ (1−40).…”
Section: Introductionmentioning
confidence: 99%
“…3−5 Increasing evidence suggests that soluble Aβ oligomers are toxic and serve as critical targets for treating AD. 6,7 Aβs with 37 to 49 amino acid residues are the peptide fragments generated by proteolytic processing of the amyloid precursor protein (APP) (Figure 1a), 8 among which the product species with chains varying in length from 38 to 42, 9 namely, Aβ (1−38), Aβ (1−40), and Aβ (1−42), are commonly detected in preclinical and clinical AD samples. 10 Further, Aβ (1−40) and Aβ (1−42) are the main components of the progressive deposition of amyloid fibrils, 5,11 and Aβ(1−42) is considered to be more neurotoxic and greater aggregative than Aβ (1−40).…”
Section: Introductionmentioning
confidence: 99%